Cargando…
Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467064/ https://www.ncbi.nlm.nih.gov/pubmed/34576213 http://dx.doi.org/10.3390/ijms221810050 |
_version_ | 1784573301392146432 |
---|---|
author | Szałabska-Rąpała, Katarzyna Borymska, Weronika Kaczmarczyk-Sedlak, Ilona |
author_facet | Szałabska-Rąpała, Katarzyna Borymska, Weronika Kaczmarczyk-Sedlak, Ilona |
author_sort | Szałabska-Rąpała, Katarzyna |
collection | PubMed |
description | Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a comprehensive approach. Introducing the aspect of non-pharmacological treatment of diabetes allows one to alleviate its many adverse complications. Therefore, it seems important to look for substances that, when included in the daily diet, can improve diabetic parameters. Magnolol, a polyphenolic compound found in magnolia bark, is known for its health-promoting activities and multidirectional beneficial effects on the body. Accordingly, the goal of this review is to systematize the available scientific literature on its beneficial effects on type 2 diabetes and its complications. Taking the above into consideration, the article collects data on the favorable effects of magnolol on parameters related to glycemia, lipid metabolism, or oxidative stress in the course of diabetes. After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases. |
format | Online Article Text |
id | pubmed-8467064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84670642021-09-27 Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review Szałabska-Rąpała, Katarzyna Borymska, Weronika Kaczmarczyk-Sedlak, Ilona Int J Mol Sci Review Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a comprehensive approach. Introducing the aspect of non-pharmacological treatment of diabetes allows one to alleviate its many adverse complications. Therefore, it seems important to look for substances that, when included in the daily diet, can improve diabetic parameters. Magnolol, a polyphenolic compound found in magnolia bark, is known for its health-promoting activities and multidirectional beneficial effects on the body. Accordingly, the goal of this review is to systematize the available scientific literature on its beneficial effects on type 2 diabetes and its complications. Taking the above into consideration, the article collects data on the favorable effects of magnolol on parameters related to glycemia, lipid metabolism, or oxidative stress in the course of diabetes. After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases. MDPI 2021-09-17 /pmc/articles/PMC8467064/ /pubmed/34576213 http://dx.doi.org/10.3390/ijms221810050 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Szałabska-Rąpała, Katarzyna Borymska, Weronika Kaczmarczyk-Sedlak, Ilona Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review |
title | Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review |
title_full | Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review |
title_fullStr | Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review |
title_full_unstemmed | Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review |
title_short | Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review |
title_sort | effectiveness of magnolol, a lignan from magnolia bark, in diabetes, its complications and comorbidities—a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467064/ https://www.ncbi.nlm.nih.gov/pubmed/34576213 http://dx.doi.org/10.3390/ijms221810050 |
work_keys_str_mv | AT szałabskarapałakatarzyna effectivenessofmagnololalignanfrommagnoliabarkindiabetesitscomplicationsandcomorbiditiesareview AT borymskaweronika effectivenessofmagnololalignanfrommagnoliabarkindiabetesitscomplicationsandcomorbiditiesareview AT kaczmarczyksedlakilona effectivenessofmagnololalignanfrommagnoliabarkindiabetesitscomplicationsandcomorbiditiesareview |